
LT Biotech was founded in 2009 and has extensive experience in both upstream and downstream products and services. The company offers a comprehensive portfolio of over 250 products for cell culture, protein purification, and diagnostics, including various cell culture media, sera, and other additives for cell growth, as well as chromatography resins for protein purification and rapid veterinary and human diagnostic testing systems. Our deep expertise enables us to deliver reliable, high-quality, and cost-effective solutions for universities, research laboratories, and small- to mid-sized biotech and pharmaceutical manufacturers.
LT Biotech is headquartered in Vilnius, Lithuania, at the Visoriai High-Tech Park, a dynamic hub for pharma, biotech, medical, solar, and space satellite electronics, and other advanced technology companies. We collaborate closely with the BOD Group, operating from some of the most environmentally friendly manufacturing buildings in Europe: the Innovation and Business Centre (IBC) and Lithuania’s incubator for green and high technologies (LIGHT), both located on Mokslininku (Scientists) Street, at numbers 2 and 6A respectively. These facilities are nearly 100% CO₂ neutral, with hundreds of geothermal wells, solar panels on the roof and facade, and smart energy storage systems, highlighting our commitment to sustainability while maintaining cutting-edge biotech production capabilities [1].
Lithuania stands at the forefront of biotechnology innovation. The country is 1st in the European Union for the proportion of secondary education graduates, with 25% of students pursuing life science programs. Lithuania ranks 3rd globally (among all OECD countries) for biotech R&D intensity, and 92%of its life sciences products are exported to over100 countries. This environment of innovation, education, and international reach enables us to provide world-class biotechnological solutions [2].